FindTrial
Sign In

A Trial of Skin Care Protocols for Facial Resurfacing

A Double-Blind, Randomized, Controlled Trial to Assess the Effects of the Obagi Nu-Derm System on Re-Epithelialization After Chemical Peel or Ablative Laser Resurfacing.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01113606
Acronym
SPAR
Enrollment
Unknown
Registered
2010-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2010-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Photo Damage, Periocular Fine Wrinkles, Perioral Fine Wrinkles

Keywords

Moderate to severe facial photo damage, Periocular or perioral fine wrinkles

Brief summary

The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.

Interventions

OTHERObagi New-Derm System
OTHERStandard of Care

Sponsors

The Plastic Surgery Foundation
Lead SponsorOTHER

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years

Inclusion criteria

* patients with moderate to severe photo damage and rhytids, undergoing full or partial face resurfacing with chemical peel or ablative laser. * Fitzpatrick I-IV skin types

Exclusion criteria

* patients unable to complete the regimen or who had used topical prescription steroids, retinoids, depigmentation products or other products containing hydroquinone and polyhydroxy acids within 8 weeks of enrollment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026